Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Aileron Therapeutics Inc.
DescriptionSelective stapled peptide dual inhibitor of Mdm2 p53 binding protein homolog (MDM2; HDM2) and MDM4
Molecular Target Mdm2 p53 binding protein homolog (MDM2) (HDM2) ; Mdm4 p53 binding protein homolog (MDM4) (MDMX)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today